Dr. Ryan Vandrey: Part 17-Can States Regulate Medical Marijuana like FDA Does?

Nov 5, 2019

Ryan G. Vandrey, PhD, is associate professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine. His research focuses on the behavioral pharmacology of marijuana in adult research volunteers, clinical trials, web-based survey research, and patients using marijuana or cannabinoids for therapeutic purposes.

Key Points

• Impact of marijuana industry deciding how to regulate itself
• Lack of industry standards based on science
• States don’t have capability, infrastructure, or financing to deliver regulation
• Testing-lab shopping to find best “safety” results
• Hemp legalization potentially a game-changer because it opens pathway for regulation by federal agencies with knowledge of regulatory science

Next Up? Dr. Compton on Predicting Future Marijuana Problems